Turn this role into an interview — a resume and cover letter built around what this employer wants.
Amgen Inc. in Hyderabad, India is seeking a results-delivery-focused Information Systems leader to own RDO capabilities, shaping change tools, platforms, and processes that scale enterprise transformation.
You will partner with technology and product teams to translate transformation needs into scalable solutions, drive adoption, define KPIs, and deliver measurable business impact in a global, matrixed environment.
Career Category Information Systems Job Description Job Description What you will do In this role, you will operate as a core member of the Results Delivery Office (RDO) capability engine, responsible for building, scaling, and driving adoption of the systems, tools, and operating processes that enable enterprise transformation at Amgen. Reporting to the Associate Director, you will act as a business owner of defined RDO capabilities—spanning change management frameworks, digital platforms, and AI-enabled solutions. You will work in close partnership with technology and product teams to translate transformation needs into scalable solutions and ensure they deliver measurable business impact. This role sits at the intersection of business strategy, transformation execution, and technology, requiring strong product thinking, operational discipline, and stakeholder influence.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen